Background For decades, conflicting results were published regarding the increased risk of
Prostate cancer (PCa) among calcium channel blocker (CCB) users. Objective We aimed to …

Purpose There is a need to better understand prostate cancer progression and identify new
prognostic markers for this tumor. We investigated the association between promoter …

The aim of our study was to estimate uptake of prostate‐specific antigen (PSA) testing in an
entire country, including time trends and geographical differences. Data from the Swedish …

The burden of prostate cancer; the natural history of the disease, including its progression;
target populations for screening; choice of screening test; results from studies of screening; …

About 3% of men in developed countries die from prostate cancer. No conclusive evidence,
however, either supports or refutes the benefit of prostate-cancer screening. More than 200 …

Background Organized PSA testing for asymptomatic men aged 50–74 years will be
implemented in Sweden to reduce opportunistic testing in groups who will not benefit. The …

The objective of this study was to analyse incidence and mortality cancer trends in the Italian
Network of Cancer Registries (about 8 000 000 inhabitants) during the period 1986–1997 …

Screening has intuitive appeal. Cancer, for example, causes a quarter of all deaths, and a
doctor does not diagnose many incurable cancers without wanting some means of bringing …

El cribado pretende identificar a las personas con una elevada probabilidad de beneficiarse
de actividades preventivas, tradicionalmente de prevención secundaria pero también de …

OBJECTIVE To examine the pattern of use of prostate‐specific antigen (PSA) testing in a UK
region, where National Health Service policy does not recommend screening for prostate …